Zephyrnet Logo

Tag: lung disease

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps | BioSpace

Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumps Subjects utilizing inhaled insulin experienced...

Top News

In New Doctor’s Office, Stethoscope Wears You

The medical professional wearing a stethoscope is a familiar image, but Northwestern University wants to change that. Instead of someone hanging an ancient device...

Combinatorial development of nebulized mRNA delivery formulations for the lungs – Nature Nanotechnology

Kowalski, P. S., Rudra, A., Miao, L. & Anderson, D. G. Delivering the messenger: advances in technologies for therapeutic mRNA delivery. Mol. Ther. 27,...

The Week’s 10 Biggest Funding Rounds: Anthropic Goes Large Again, Sierra Space Blasts Off

Want to keep track of the largest startup funding deals in 2023 with our new curated list of $100 million-plus venture deals...

Datopotamab Deruxtecan Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival Benefit in Patients with HR-Positive, HER2-Low or Negative Breast Cancer in TROPION-Breast01 Phase III...

A trend in improvement for the dual primary endpoint of overall survival (OS) was observed for datopotamab deruxtecan versus chemotherapy. Data for OS were...

AstraZeneca and Daiichi’s next cancer medicine scores in breast tumors

Dive Brief: A new cancer drug developed by Daiichi Sankyo and AstraZeneca met one of its two main goals in a breast cancer trial, helping...

Understanding the idiopathic pulmonary fibrosis patient community [whitepaper]

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that results in weakened breathing and reduced lung function. In the U.S., it is estimated...

Waiter With Terminal Lung Cancer Sues Crown Melbourne

No warnings A waiter who has terminal lung cancer is suing the Crown Melbourne casino, alleging that his time working in the high roller...

Trial-first for Roche lung cancer ALK inhibitor

Roche has provided the first evidence that its oral anaplastic lymphoma kinase (ALK) inhibitor for non-small cell lung cancer (NSCLC) could be key in...

Spexis AG bags money for pivital Phase III trial

Swiss Spexis AG  has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its...

Spexis AG bags money for pivotal Phase III trial

Swiss Spexis AG  has announced a US$2.5m capital commitment to fund a two-part pivotal Phase III study to get market approval for its...

Eli Lilly meets primary endpoint in LIBRETTO-431 study for NSCLC

<!----> Eli Lilly has met the primary endpoint in the LIBRETTO-431 study evaluating Retevmo versus platinum-based chemotherapy plus...

How to Protect Yourself From Wildfire Smoke – EcoWatch

Hundreds of wildfires originating in Canada descended over the midwest and eastern U.S. this June. While some regions in the west and in...

Latest Intelligence

spot_img
spot_img